S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LCTX Lineage Cell Therapeutics Inc

1.08

0.03 (2.86%)

Last Updated: 12:31:53

Delayed by 15 minutes

Lineage Cell extends gains after announcing collaboration with Neurgain

To read the full story on Seeking Alpha, click here.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

More Lineage Cell Therapeutics Inc News Articles

Brookmount Explorations (PK)

RespireRx Pharmaceuticals (PK)

Global Developments (PK)

Voip Pal Com (QB)

MicroCloud Hologram

Yuenglings Ice Cream (PK)

Auto Parts 4Less (PK)

Bell Buckle (PK)

Globestar Therapeutics (PK)

Moon Equity (PK)

NaturalShrimp (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions